Interactive Brokers Group Inc. Class A Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Interactive Brokers Group Inc. Class A Common Stock trades at $86.6 (market cap $39.76B), while ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B). The key difference: Interactive Brokers Group Inc. Class A Common Stock is far larger — about 3.8× ImmunityBio Inc. Common Stock's market cap, and Interactive Brokers Group Inc. Class A Common Stock pays a 0.4% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Interactive Brokers Group Inc. Class A Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| IBKR | IBRX | |
|---|---|---|
Market Cap | $39.76B | $10.33B |
Volume | 3,648,999 | 11,745,198 |
Sector | Financials | Health |
52-Week High | $98.19 | $11.55 |
52-Week Low | $61.05 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $32.06B | $10.79B |
Dividend Yield | 0.4% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Interactive Brokers operates an electronic brokerage platform for trading stocks, options, futures, currencies, and other assets. It also provides clearing and custody services.
Read more on IBKR →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →